hephaistos.bio
Agent26Agent Readiness: 26/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Trust61Data Trust: 61/100. Above median. Measured by StartupHub.ai. Median 61.Designing custom enzyme solutions for pharmaceutical and chemical manufacturing.
About
hephaistos.bio is a Swiss biotech startup that develops custom enzyme solutions for pharmaceutical and chemical manufacturing. They leverage computational biology, chemistry, machine learning, and structural biology to design biocatalysts for reactions that are difficult or impossible to perform efficiently with existing solutions. Their platform aims to improve sustainability, resilience, and cost efficiency for manufacturers, with a focus on enabling reshoring of production to Europe.
Key facts
At-a-glance profile data
- Website
- perlin.bio
- Headquarters
- Zurich, Switzerland
- Employees
- 5
- Total funding
- $175K (Pre-Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jun 2026 | Pre-Seed | $175K | Venture Kick |
Tech stack
Detected on perlin.bio, last scanned 24 Sept 2026. Run your own scan
- CDN
- Vercel
- Email provider
- Google Workspace
Frequently asked
Is hephaistos.bio trustworthy and reputable?
StartupHub's Data Trust & Reputation score for hephaistos.bio is 61 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has hephaistos.bio raised?
hephaistos.bio has raised a total of $175K in funding. The most recent round on record is Pre-Seed.
How many employees does hephaistos.bio have?
hephaistos.bio has approximately 5 people on record.